- About Us
- Services & Solutions
- Nucleic Acid Vaccines
- Viral Vector Vaccines
Offering End-to-End Solutions
We offer state-of-the-art cell culture development labs and a non-GMP pilot plant specializing in the process development, characterization, validation and process scale-up to establish successful cGMP clinical and commercial manufacturing. To support all stages of vaccines development from preclinical to commercial production, we employ traditional fed-batch, continuous, and/or intensified processes based on your specific project needs.
8 upstream development labs are equipped with a wide variety of cell culture production systems and analytical tools such as 1L to 15L traditional glass bioreactors, perfusion systems to support intensified and/or continuous processes, high throughput AMBRTM systems (AMBR15 and AMBR250), Finesse and Applikon Controllers with Delta V systems, Wave bioreactors, and Cedex Bio HT high throughput bio-analyzers.
IND-enabling cell culture activities
Early stage (Phase I-II) and late stage (Phase III) cell culture process development
Product Quality Optimization
Product quality optimization is an essential part of bioprocess development. We have developed a comprehensive toolbox for the optimization of various product quality attributes, that include: